• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

下肢动脉疾病血管内治疗的最新趋势及介入放射科医生的建议：展望未来继续投身该领域。

Latest Trend of Endovascular Treatment for Lower Extremity Artery Disease and Recommendations from Interventional Radiologist: To Continue Engaging in This Field Moving Forward.

作者信息

Endo Masayuki, Yata Shinsaku, Takasugi Shohei, Yamamoto Shuichi, Kamata Yuji, Makishima Jun, Kishimoto Misato, Shinano Kentaro, Fujii Shinya

机构信息

Division of Radiology, Department of Multidisciplinary Internal Medicine, Tottori University, Japan.

Department of Radiology, Matsue City Hospital, Japan.

出版信息

Interv Radiol (Higashimatsuyama). 2025 Jun 30;10:e20240052. doi: 10.22575/interventionalradiology.2024-0052. eCollection 2025.

DOI:10.22575/interventionalradiology.2024-0052
PMID:40918237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12408231/
Abstract

Lower extremity artery disease affects more than 230 million people worldwide, leading to significant cardiovascular and limb-related complications. Recent advancements in endovascular treatment, driven by technological innovations and increasing patient prevalence due to aging populations and lifestyle diseases, has contributed to a growing demand for endovascular treatment. In Japan, the number of endovascular treatment procedures has increased specifically among cardiologists, whereas the involvement of interventional radiology physicians remains limited. This review explores the latest trends and clinical outcomes of endovascular treatment, and the importance of multidisciplinary collaboration, including the role of interventional radiology physicians. The findings encourage greater involvement of interventional radiology physicians in endovascular treatment.

摘要

下肢动脉疾病影响着全球超过2.3亿人，会导致严重的心血管和肢体相关并发症。由于技术创新以及老龄化人口和生活方式疾病导致患者患病率上升，血管内治疗最近取得了进展，这使得对血管内治疗的需求不断增加。在日本，血管内治疗程序的数量在心脏病专家中尤其有所增加，而介入放射科医生的参与度仍然有限。本综述探讨了血管内治疗的最新趋势和临床结果，以及多学科协作的重要性，包括介入放射科医生的作用。这些发现鼓励介入放射科医生更多地参与血管内治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/908c3c74a18b/2432-0935-10-e2024-0052-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/6fccf6da8f89/2432-0935-10-e2024-0052-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/4f26a7735b21/2432-0935-10-e2024-0052-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/2d5269316962/2432-0935-10-e2024-0052-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/bbf086852aed/2432-0935-10-e2024-0052-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/3afc640eb875/2432-0935-10-e2024-0052-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/908c3c74a18b/2432-0935-10-e2024-0052-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/6fccf6da8f89/2432-0935-10-e2024-0052-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/4f26a7735b21/2432-0935-10-e2024-0052-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/2d5269316962/2432-0935-10-e2024-0052-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/bbf086852aed/2432-0935-10-e2024-0052-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/3afc640eb875/2432-0935-10-e2024-0052-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/843b/12408231/908c3c74a18b/2432-0935-10-e2024-0052-g006.jpg

相似文献

1
Latest Trend of Endovascular Treatment for Lower Extremity Artery Disease and Recommendations from Interventional Radiologist: To Continue Engaging in This Field Moving Forward.下肢动脉疾病血管内治疗的最新趋势及介入放射科医生的建议：展望未来继续投身该领域。
Interv Radiol (Higashimatsuyama). 2025 Jun 30;10:e20240052. doi: 10.22575/interventionalradiology.2024-0052. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方：益处与风险
3
The impact of postoperative dual antiplatelet therapy on outcomes of endovascular therapies in patients with chronic limb-threatening ischemia in the Vascular Quality Initiative-Medicare-linked database.血管质量倡议-医疗保险关联数据库中术后双重抗血小板治疗对慢性肢体威胁性缺血患者血管内治疗结局的影响
J Vasc Surg. 2025 Mar 18. doi: 10.1016/j.jvs.2025.03.177.
4
Temporal trends and outcomes of patients with chronic limb-threatening ischemia with and without history of coronary artery disease: insights from the us national inpatient sample database.有和无冠状动脉疾病史的慢性肢体威胁性缺血患者的时间趋势和结局：来自美国国家住院患者样本数据库的见解。
J Invasive Cardiol. 2023 Oct;35(10). doi: 10.25270/jic/23.00191.
5
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果：来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
6
Characteristics of Multidisciplinary Limb Preservation Teams and their Impact on Outcomes in the BEST-CLI Trial.多学科肢体保全团队的特征及其对BEST-CLI试验结果的影响。
J Vasc Surg. 2025 Aug 28. doi: 10.1016/j.jvs.2025.08.028.
7
Comparison of isolated popliteal interventions in chronic limb-threatening ischemia.慢性肢体威胁性缺血中孤立腘动脉干预措施的比较
J Vasc Surg. 2025 Sep;82(3):941-951.e1. doi: 10.1016/j.jvs.2025.03.193. Epub 2025 Mar 26.
8
Bypass surgery for chronic lower limb ischaemia.慢性下肢缺血的搭桥手术。
Cochrane Database Syst Rev. 2017 Apr 3;4(4):CD002000. doi: 10.1002/14651858.CD002000.pub3.
9
Systematic review on radiation-induced DNA damage and cancer risk in endovascular operators.血管内介入操作人员辐射诱发DNA损伤与癌症风险的系统评价
J Vasc Surg. 2025 Aug 26. doi: 10.1016/j.jvs.2025.07.058.
10
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理（2025年结石病专家共识）
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

本文引用的文献

1
Clinical Outcomes of Transradial vs Nontransradial Aortoiliac Endovascular Therapy.经桡动脉与非经桡动脉腹主动脉瘤腔内治疗的临床结局比较。
JACC Cardiovasc Interv. 2024 Aug 26;17(16):1891-1901. doi: 10.1016/j.jcin.2024.06.002.
2
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.对于需要进行 below-the-knee（小腿）、伴或不伴额外更近端 below-inguinal（腹股沟下）血运重建以恢复肢体灌注的慢性肢体威胁性缺血患者，静脉旁路优先与最佳血管内治疗优先再血管化策略的比较（BASIL-2）：一项开放标签、随机、多中心、3 期试验。
Lancet. 2023 May 27;401(10390):1798-1809. doi: 10.1016/S0140-6736(23)00462-2. Epub 2023 Apr 25.
3
Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion.股腘动脉病变药物涂层球囊血管通畅率及其相关因素
J Am Heart Assoc. 2023 Jan 3;12(1):e025677. doi: 10.1161/JAHA.122.025677. Epub 2022 Dec 30.
4
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.慢性肢体威胁性缺血的手术或血管内治疗。
N Engl J Med. 2022 Dec 22;387(25):2305-2316. doi: 10.1056/NEJMoa2207899. Epub 2022 Nov 7.
5
Long-Term Clinical Outcomes of Iliac Artery Endovascular Therapy in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry.韩国血管介入学会下肢动脉疾病腔内治疗（K-VIS ELLA）注册研究中髂动脉腔内治疗的长期临床结果。
Korean Circ J. 2022 Jul;52(7):529-540. doi: 10.4070/kcj.2021.0390. Epub 2022 Mar 28.
6
1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice: Predictors of Restenosis and Aneurysmal Degeneration.股腘动脉腔内治疗中氟聚合物载药支架 1 年随访结果：再狭窄和瘤样扩张的预测因素。
JACC Cardiovasc Interv. 2022 Mar 28;15(6):630-638. doi: 10.1016/j.jcin.2022.01.019.
7
Clinical outcomes of endovascular treatment for chronic aortic occlusion: a retrospective multicentre registry: EVT for chronic aortic occlusion.慢性主动脉闭塞血管内治疗的临床结局：一项回顾性多中心注册研究：慢性主动脉闭塞的血管内治疗
AsiaIntervention. 2019 Jul;5(2):121-127. doi: 10.4244/AIJ-D-18-00050. Epub 2019 Jul 20.
8
Clinical outcomes of endovascular procedure using VIABAHN® VBX covered stent in complex aortoiliac artery disease: Result from AVOCADO study.使用VIABAHN® VBX覆膜支架治疗复杂主髂动脉疾病的血管内介入治疗临床结果：AVOCADO研究结果
Catheter Cardiovasc Interv. 2021 Nov 1;98(5):928-937. doi: 10.1002/ccd.29920. Epub 2021 Aug 18.
9
Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association.下肢外周动脉疾病：当代流行病学、管理差距与未来方向：美国心脏协会科学声明。
Circulation. 2021 Aug 31;144(9):e171-e191. doi: 10.1161/CIR.0000000000001005. Epub 2021 Jul 28.
10
Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease.紫杉醇涂层器械在外周动脉疾病中的死亡率。
N Engl J Med. 2020 Dec 24;383(26):2538-2546. doi: 10.1056/NEJMoa2005206. Epub 2020 Dec 9.